Extrawell Pharmaceutical Plans Private Placement to Raise Up to HK$ 30.2 Million

• Extrawell Pharmaceutical on October 30, 2026, agreed to privately place up to 580,000,000 new shares at HK$ 0.052 each.
• The placement would raise approximately HK$ 30.2 million gross, yielding HK$ 29.4 million net; new shares represent 16.67% of enlarged capital.
• The placement price represents a 1.96% premium to the last closing price of HK$ 0.051.
• Proceeds will allocate HK$ 9.8 million to electronic modules trading expansion, with HK$ 19.6 million supporting manufacturing, sales and research and development.
• Completion requires stock exchange listing approval by November 13, 2026, unless extended, and is scheduled within five business days of approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extrawell Pharmaceutical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12391689), on October 30, 2026, and is solely responsible for the information contained therein.